Current and emerging imaging in relation to drug discovery in airways disease

Pulmonary Pharmacology and Therapeutics

Volumn 24, Issue 5, 2011, Pages 497-504

  King, Gregory G ^a,b,c,d  

^a WOOLCOCK INSTITUTE OF MEDICAL RESEARCH   (Australia)

^b UNIVERSITY OF SYDNEY   (Australia)

^c Cooperative Research Centre for Asthma and Airways ^*  (Australia)

^d ROYAL NORTH SHORE HOSPITAL   (Australia)

Author keywords

Airways; Three dimensional pulmonary imaging; Ventilation

Indexed keywords

BIOLOGICAL MARKER; CORTICOSTEROID; FLUORODEOXYGLUCOSE F 18; LEUKOTRIENE RECEPTOR BLOCKING AGENT; PENTETIC ACID; TECHNETIUM 99M; XENON;

ARTICLE; ASTHMA; BRONCHIECTASIS; BRONCHOSCOPY; CHRONIC OBSTRUCTIVE LUNG DISEASE; CONTRAST ENHANCEMENT; CORTICOSTEROID THERAPY; COST BENEFIT ANALYSIS; CYSTIC FIBROSIS; DISEASE SEVERITY; DRUG HALF LIFE; DRUG RESEARCH; DRUG UPTAKE; FORCED EXPIRATORY VOLUME; FUNCTIONAL RESIDUAL CAPACITY; HIGH RESOLUTION COMPUTER TOMOGRAPHY; HUMAN; IMAGE RECONSTRUCTION; IN VIVO STUDY; INFLAMMATION; LUNG EMBOLISM; LUNG EMPHYSEMA; LUNG FIBROSIS; LUNG PARENCHYMA; LUNG VENTILATION; LUNG VENTILATION DISTRIBUTION; MEASUREMENT; MOLECULAR IMAGING; NONHUMAN; NUCLEAR MAGNETIC RESONANCE IMAGING; PHENOTYPE; POSITRON EMISSION TOMOGRAPHY; PRIORITY JOURNAL; RADIATION EXPOSURE; RESPIRATORY TRACT DISEASE; SINGLE PHOTON EMISSION COMPUTER TOMOGRAPHY; STRUCTURE ACTIVITY RELATION; SYNCHROTRON RADIATION; THORAX RADIOGRAPHY; THREE DIMENSIONAL IMAGING;

ANIMALS; DRUG DISCOVERY; HUMANS; IMAGING, THREE-DIMENSIONAL; MAGNETIC RESONANCE IMAGING; POSITRON-EMISSION TOMOGRAPHY; RESPIRATORY TRACT DISEASES; TOMOGRAPHY, EMISSION-COMPUTED, SINGLE-PHOTON; TOMOGRAPHY, X-RAY COMPUTED;

EID: 80052402165     PISSN: 10945539     EISSN: 15229629     Source Type: Journal    
DOI: 10.1016/j.pupt.2011.07.003     Document Type: Article

References (83)

1. Müller N.L., Staples C.A., Miller R.R., Abboud R.T. Density mask. An objective method to quantitate emphysema using computed tomography. Chest 1988, 94(4):782-787.
2. Coxson H.O., Mayo J.R., Behzad H., Moore B.J., Verburgt L.M., Staples C.A., et al. Measurement of lung expansion with computed tomography and comparison with quantitative histology. J Appl Physiol 1995, 79(5):1525-1530.
3. Coxson H.O., Rogers R.M., Whittall K.P., D'Yachkova Y., Pare P.D., Sciurba F.C., et al. A quantification of the lung surface area in emphysema using computed tomography. Am J Respir Crit Care Med 1999, 159(3):851-856.
4. Woods J.C., Choong C.K., Yablonskiy D.A., Bentley J., Wong J., Pierce J.A., et al. Hyperpolarized 3He diffusion MRI and histology in pulmonary emphysema. Magn Reson Med 2006, 56(6):1293-1300.
5. Mair G., Miller J.J., McAllister D., Maclay J., Connell M., Murchison J.T., et al. Computed tomographic emphysema distribution: relationship to clinical features in a cohort of smokers. Eur Respir J March 1, 2009, 33(3):536-542.
6. Nakano Y., Sakai H., Muro S., Hirai T., Oku Y., Nishimura K., et al. Comparison of low attenuation areas on computed tomographic scans between inner and outer segments of the lung in patients with chronic obstructive pulmonary disease: incidence and contribution to lung function. Thorax 1999, 54(5):384-389.
7. Mishima M., Hirai T., Itoh H., Nakano Y., Sakai H., Muro S., et al. Complexity of terminal airspace geometry assessed by lung computed tomography in normal subjects and patients with chronic obstructive pulmonary disease. Proc Natl Acad Sci USA 1999, 96(16):8829-8834.
8. Uppaluri R., Mitsa T., Sonka M., Hoffman E.A., McLennan G. Quantification of pulmonary emphysema from lung computed tomography images. Am J Respir Crit Care Med 1997, 156(1):248-254.
9. King G., Müller N., Whittall K., Xiang Q., Paré P. An analysis algorithm for measuring airway lumen and wall areas from high-resolution computed tomographic data. Am J Resp Crit Care Med 2000, 161(2):574-580.
10. Dame Carroll J.R., Chandra A., Jones A.S., Berend N., Magnussen J.S., King G.G. Airway dimensions measured from micro-computed tomography and high-resolution computed tomography. Eur Respir J October 1, 2006, 28(4):712-720.
11. Nakano Y., M√°ller N.L., King G.G., Niimi A., Kalloger S.E., Mishima M., et al. Quantitative assessment of airway Remodeling using high-resolution CT*. Chest December 1, 2002, 122(6 suppl):271S-275S.
12. Wood S.A., Zerhouni E.A., Hoford J.D., Hoffman E.A., Mitzner W. Measurement of three-dimensional lung tree structures by using computed tomography. J Appl Physiol 1995, 79(5):1687-1697.
13. McNamara A.E., Müller N.L., Okazawa M., Arntorp J., Wiggs B.R., Paré P.D. Airway narrowing in excised canine lungs measured by high-resolution computed tomography. J Appl Physiol 1992, 73(1):307-316.
14. Nakano Y., Muro S., Sakai H., Hirai T., Chin K., Tsukino M., et al. Computed tomographic measurements of airway dimensions and emphysema in smokers. Correlation with lung function. Am J Respir Crit Care Med 2000, 162(3 Pt 1):1102-1108.
15. Kitaguchia Y., Fujimotoa K., Kuboa K., Honda T. Characteristics of COPD phenotypes classified according to the findings of HRCT. Respir Med 2006, 100(10):1742-1752.
16. Orlandi I., Moroni C., Camiciottoli G., Bartolucci M., Pistolesi M., Villari N., et al. Chronic obstructive pulmonary disease: thin-Section CT measurement of airway wall thickness and lung attenuation. Radiology 2005, 234(2):604-610.
17. Grydeland T.B., Dirksen A., Coxson H.O., Eagan T.M.L., Thorsen E., Pillai S.G., et al. Quantitative computed tomography measures of emphysema and airway wall thickness are related to respiratory symptoms. Am J Respir Crit Care Med February 15, 2010, 181(4):353-359.
18. Kuwano K., Bosken C., Pare P., Bai T., Wiggs B., Hogg J. Small airways dimensions in asthma and in chronic obstructive pulmonary disease. Am Rev Respir Dis 1993, 148:1220-1225.
19. Aysola R.S., Hoffman E.A., Gierada D., Wenzel S., Cook-Granroth J., Tarsi J., et al. Airway remodeling measured by multidetector CT is increased in severe asthma and correlates with Pathology. Chest 2008, 134(6):1183-1191.
20. Okazawa M., Müller N.L., McNamara A.E., Child S., Verburgt L., Paré P.D. Human airway narrowing measured using high resolution computed tomography. Am J Respir Crit Care Med 1996, 154:1557-1562.
21. Awadh N., Müller N.L., Park C.S., Abboud R.T., Fitzgerald J.M. Airway wall thickness in patients with near fatal asthma and control groups: assessment with high resolution computed tomographic scanning. Thorax 1998, 53:248-253.
22. Niimi A., Matsumoto H., Amitani R., Nakano Y., Mishima M., Minakuchi M., et al. Airway wall thickness in asthma assessed by computed tomography. Relation to clinical Indices. Am J Respir Crit Care Med October 1, 2000, 162(4):1518-1523.
23. Brown R.H., Scichilone N., Mudge B., Diemer F.B., Permutt S., Togias A. High-resolution computed tomographic evaluation of airway distensibility and the effects of lung inflation on airway Caliber in healthy subjects and individuals with asthma. Am J Respir Crit Care Med March 15, 2001, 163(4):994-1001.
24. Kasahara K., Shiba K., Ozawa T., Okuda K., Adachi M. Correlation between the bronchial subepithelial layer and whole airway wall thickness in patients with asthma. Thorax March 1, 2002, 57(3):242-246.
25. Little S.A., Sproule M.W., Cowan M.D., Macleod K.J., Robertson M., Love J.G., et al. High resolution computed tomographic assessment of airway wall thickness in chronic asthma: reproducibility and relationship with lung function and severity. Thorax March 1, 2002, 57(3):247-253.
26. Niimi A., Matsumoto H., Amitani R., Nakano Y., Sakai H., Takemura M., et al. Effect of short-term treatment with inhaled corticosteroid on airway wall thickening in asthma. Am J Med 2004/06/01, 116(11):725-731.
27. Niimi A., Matsumoto H., Takemura M., Ueda T., Chin K., Mishima M. Relationship of airway wall thickness to airway Sensitivity and airway Reactivity in asthma. Am J Respir Crit Care Med October 15, 2003, 168(8):983-988.
28. Brown R., Mitzner W. Effect of lung inflation and airway muscle tone on airway diameter in vivo. J Appl Physiol 1996, 79:1581-1588.
29. Kelly V.J., Brown N.J., King G.G., Thompson B. A method to determine in vivo, specific airway compliance, in humans. Med Biol Eng Comput 2010, 48(5):489-496.
30. Kelly V.J., Brown N.J., King G.G., Thompson B. The bronchodilator response of in vivo airway compliance in adults with asthma. Ann Biomed Eng 2011, 39(3):1125-1135.
31. King G.G., Carroll J.D., Muller N.L., Whittall K.P., Gao M., Nakano Y., et al. Heterogeneity of narrowing in normal and asthmatic airways measured by HRCT. Eur Respir J August 1, 2004, 24(2):211-218.
32. Fowler W.S. Lung function studies. II. The respiratory dead space. Am J Physiol September 1, 1948, 154(3):405-416.
33. Crawford A.B., Makowska M., Paiva M., Engel L.A. Convection- and diffusion-dependent ventilation maldistribution in normal subjects. J Appl Physiol 1985, 59(3):838-846.
34. Verbanck S., Paiva M. Model simulations of gas mixing and ventilation distribution in the human lung. J Appl Physiol 1990 Dec, 69(6):2269-2279.
35. Zeidler M.R., Kleerup E.C., Goldin J.G., Kim H.J., Truong D.A., Simmons M.D., et al. Montelukast improves regional air-trapping due to small airways obstruction in asthma. Eur Respir J February 1, 2006, 27(2):307-315.
36. Downie S., Salome C., Verbanck S., Thompson B., Berend N., King G. Ventilation heterogeneity is a major determinant of airway hyperresponsiveness in asthma, independent of airway inflammation. Thorax 2007, 62(8):684-689.
37. Bourdin A., Paganin F., Préfaut C., Kieseler D., Godard P., Chanez P. Nitrogen washout slope in poorly controlled asthma. Allergy 2006, 61(1):85-89.
38. in 't Veen J.C., Beekman A.J., Bel E.H., Sterk P.J. Recurrent exacerbations in severe asthma are associated with enhanced airway closure during stable episodes. Am J Respir Crit Care Med 2000 Jun, 161(6):1902-1906.
39. Busacker A., Newell J.D., Keefe T., Hoffman E.A., Granroth J.C., Castro M., et al. A Multivariate analysis of risk factors for the air-trapping asthmatic phenotype as measured by quantitative CT analysis. Chest 2009, 135(1):48-56.
40. Chae E.J., Seo J.B., Lee J., Kim N., Goo H.W., Lee H.J., et al. Xenon ventilation imaging using dual-energy computed tomography in asthmatics: initial experience. Invest Radiol 2010, 45(6):354-361. 10.1097/RLI.0b013e3181dfdae0.
41. Sase S., Nakano H., Suzuki H., Honda M. Subtraction lung image for evaluating pulmonary ventilation in xenon-enhanced CT. Med Phys 2010 Aug, 37(8):4464-4474.
42. Samee S., Altes T., Powers P., de Lange E.E., Knight-Scott J., Rakes G., et al. Imaging the lungs in asthmatic patients by using hyperpolarized helium-3 magnetic resonance: assessment of response to methacholine and exercise challenge. J Allergy Clin Immunol 2003 Jun, 111(6):1205-1211. see comment.
43. Tzeng Y.-S., Lutchen K., Albert M. The difference in ventilation heterogeneity between asthmatic and healthy subjects quantified using hyperpolarized 3He MRI. J Appl Physiol March 1, 2009, 106(3):813-822.
44. Fain S.B., Gonzalez-Fernandez G., Peterson E.T., Evans M.D., Sorkness R.L., Jarjour N.N., et al. Evaluation of structure-function relationships in asthma using Multidetector CT and hyperpolarized He-3 MRI. Acad Rad 2008, 15(6):753-762.
45. Fain S.B., Peterson E.T., Sorkness R.L., Wenzel S., Castro M., Busse W.W. Severe asthma research Program - phenotyping and quantification of severe asthma. Imaging Decis MRI 2009, 13(1):24-27.
46. Mugler J.P., Altes T.A., Ruset I.C., Dregely I.M., Mata J.F., Miller G.W., et al. Simultaneous magnetic resonance imaging of ventilation distribution and gas uptake in the human lung using hyperpolarized xenon-129. Proc Natl Acad Sci December 14, 2010, 107(50):21707-21712.
47. Brown R., Woolcock A.J., Vincent N.J., Macklem P.T. Physiological effects of experimental airway obstruction with beads. J Appl Physiol 1969, 27(3):328-335.
48. Peterson E.T., Dai J., Holmes J.H., Fain S.B. Measurement of lung airways in three dimensions using hyperpolarized helium-3 MRI. Phys Med Biol 2011, 56(10):3107.
49. Woods J.C., Yablonskiy D.A., Choong C.K., Chino K., Pierce J.A., Hogg J.C., et al. Long-range diffusion of hyperpolarized 3He in explanted normal and emphysematous human lungs via magnetization tagging. J Appl Physiol November 1, 2005, 99(5):1992-1997.
50. Ohno Y., Koyama H., Nogami M., Takenaka D., Matsumoto S., Obara M., et al. Dynamic oxygen-enhanced MRI versus quantitative CT: pulmonary functional Loss assessment and clinical stage classification of smoking-related COPD. Am J Roentgenol February 1, 2008, 190(2):W93-W99.
51. Sá R.C., Cronin M.V., Cortney Henderson A., Holverda S., Theilmann R.J., Arai T.J., et al. Vertical distribution of specific ventilation in normal supine humans measured by oxygen-enhanced proton MRI. J Appl Physiol December 1, 2010, 109(6):1950-1959.
52. de Lange E.E., Altes T.A., Patrie J.T., Gaare J.D., Knake J.J., Mugler J.P., et al. Evaluation of asthma with hyperpolarized Helium-3 MRI: correlation with clinical severity and spirometry. Chest October 1, 2006, 130(4):1055-1062.
53. Coxson H.O., Mayo J.R., Lam S., Santyr G., Parraga G., Sin D.D. Pulmonary perspective: new and current clinical imaging techniques to study chronic obstructive pulmonary disease. Am J Respir Crit Care Med 2009, 180:589-597.
54. Mathew L., Kirby M., Etemad-Rezai R., Wheatley A., McCormack D., Parraga G. Hyperpolarized (3)He magnetic resonance imaging: preliminary evaluation of phenotyping potential in chronic obstructive pulmonary disease. Eur J Radiol 2009 Nov 20, 20:20. Journal article.
55. de Lange E.E., Altes T.A., Patrie J.T., Battiston J.J., Juersivich A.P., Mugler J.P., et al. Changes in regional airflow obstruction over time in the lungs of patients with asthma: evaluation with 3He MR imaging. Radiology February 1, 2009, 250(2):567-575.
56. Verbanck S., Schuermans D., Noppen M., Van Muylem A., Paiva M., Vincken W. Evidence of Acinar airway Involvement in asthma. Am J Respir Crit Care Med May 1, 1999, 159(5):1545-1550.
57. Campana L., Kenyon J., Zhalehdoust-Sani S., Tzeng Y.-S., Sun Y., Albert M., et al. Probing airway conditions governing ventilation defects in asthma via hyperpolarized MRI image functional modeling. J Appl Physiol 2009, 106:1293-1300.
58. Bayat S., Porra L., Suhonen H., Janosi T., Strengell S., Habre W., et al. Imaging of lung function using synchrotron radiation computed tomography: what's new?. Eur J Radiol 2008 Dec, 68(3 Suppl):S78-S83.
59. Kitchen M., Lewis R., Morgan M., Wallace M., Siew M., Siu K., et al. Dynamic measures of regional lung air volume using phase contrast x-ray imaging. Phys Med Biol 2008, 53(21):6065-6077.
60. Bayat S., Strengell S., Porra L., Janosi T.Z., Petak F., Suhonen H., et al. Methacholine and ovalbumin challenges assessed by Forced Oscillations and synchrotron lung imaging. Am J Respir Crit Care Med August 15, 2009, 180(4):296-303.
61. Siu K.K.W., Morgan K.S., Paganin D.M., Boucher R., Uesugi K., Yagi N., et al. Phase contrast X-ray imaging for the non-invasive detection of airway surfaces and lumen characteristics in mouse models of airway disease. Eur J Radiol 2008, 68(3):S22-S26.
62. Lundblad L.K.A., Thompson-Figueroa J., Allen G.B., Rinaldi L., Norton R.J., Irvin C.G., et al. Airway hyperresponsiveness in allergically inflamed Mice: the role of airway closure. Am J Respir Crit Care Med April 15, 2007, 175(8):768-774.
63. Froese A.R., Ask K., Labiris R., Farncombe T., Warburton D., Inman M.D., et al. Three-dimensional computed tomography imaging in an animal model of emphysema. Eur Respir J December 1, 2007, 30(6):1082-1089.
64. Ask K., Labiris R., Farkas L., Moeller A., Froese A., Farncombe T., et al. Comparison between conventional and "clinical" assessment of experimental lung fibrosis. J Translational Med 2008, 6(1):16.
65. Musch G., Layfield J.D.H., Harris R.S., Melo M.F.V., Winkler T., Callahan R.J., et al. Topographical distribution of pulmonary perfusion and ventilation, assessed by PET in supine and prone humans. J Appl Physiol November 1, 2002, 93(5):1841-1851.
66. Harris R.S., Winkler T., Tgavalekos N., Musch G., Melo M.F.V., Schroeder T., et al. Regional pulmonary perfusion, inflation, and ventilation defects in Bronchoconstricted patients with asthma. Am J Respir Crit Care Med August 1, 2006, 174:245-253.
67. Jones H., Marino P., Shakur B., Morrell N. In vivo assessment of lung inflammatory cell activity in patients with COPD and asthma. Eur Respir J 2003, 21(4):567-573.
68. 99mTechnetium labelled ultrafine carbon particle aerosol (Technegas) in human lungs. Eur Respir J 1990, 3:679-685.
69. 99mTechnetium labelled ultrafine carbon aerosol (Technegas) in severe airflow obstruction. Eur Respir J 1990, 3:686-692.
70. King G.G., Eberl S., Salome C.M., Meikle S.R., Woolcock A.J. Airway closure measured by a Technegas bolus and SPECT. Am J Respir Crit Care Med 1997, 155(2):682-688.
71. King G.G., Eberl S., Salome C.M., Young I.H., Woolcock A.J. Differences in airway closure between normals and asthmatics measured by SPECT and Technegas. Am J Respir Crit Care Med 1998, 158(6):1900-1908.
72. Pellegrino R., Biggi A., Papaleo A., Camuzzini G., Rodarte J.R., Brusasco V. Regional expiratory flow limitation studied with Technegas in asthma. J Appl Physiol November 1, 2001, 91(5):2190-2198.
73. King G., Mahadev S., Harris B. Ventilation/Perfusion SPECT: utility for investigation of pulmonary physiology. Semin Nucl Med 2010, 40(6):467-473.
74. Nagao M., Murase K., Ichiki T., Sakai S., Yasuhara Y., Ikezoe J. Quantitative analysis of Technegas SPECT: evaluation of regional severity of emphysema. J Nucl Med April 1, 2000, 41(4):590-595.
75. Nagao M., Murase K. Measurement of heterogeneous distribution on Technegas SPECT images by three-dimensional fractal analysis. Ann Nucl Med 2002, 16(6):369-376. 10.1007/BF02990073.
76. Wagner P.D., Hedenstierna G., Rodriguez-Roisin R. Gas exchange, expiratory flow obstruction and the clinical spectrum of asthma. Eur Respir J 1996, 9(6):1278-1282.
77. Barbera J., Ramirez J., Roca J., Wagner P., Sanchez-Lloret J., Rodriguez-Roisin R. Lung structure and gas exchange in mild chronic obstructive pulmonary disease. Am Rev Respir Dis 1990, 141(4):895-901.
78. Petersson J., Sanchez-Crespo A., Rohdin M., Montmerle S., Nyren S., Jacobsson H., et al. Physiological evaluation of a new quantitative SPECT method measuring regional ventilation and perfusion. J Appl Physiol 2004 Mar, 96(3):1127-1136. Epub 2003 Nov 14.
79. Sánchez-Crespo A., Petersson J., Nyren S., Mure M., Glenny R., Thorell J.-O., et al. A novel quantitative dual-isotope method for simultaneous ventilation and perfusion lung SPET. Eur J Nucl Med Mol Imaging 2002, 29(7):863-875.
80. Eberl S., Chan H.-K., Daviskas E., Constable C., Young I. Aerosol deposition and clearance measurement: a novel technique using dynamic SPET. Eur J Nucl Med Mol Imaging 2001, 28(9):1365-1372. 10.1007/s002590100586.
81. Daviskas E., Anderson S., Gonda I., Eberl S., Meikle S., Seale J., et al. Inhalation of hypertonic saline aerosol enhances mucociliary clearance in asthmatic and healthy subjects. Eur Respir J April 1, 1996, 9(4):725-732.
82. Leach C.L., Bethke T.D., Boudreau R.J., Hasselquist B.E., Drollmann A., Davidson P., et al. Two-Dimensional and three-dimensional imaging show Ciclesonide has high lung deposition and peripheral distribution: a Nonrandomized study in healthy Volunteers. J Aerosol Med 2006, 19(2):117-126.
83. Eberl S., Chan H.-K., Daviskas E. SPECT imaging for radioaerosol deposition and clearance studies. J Aerosol Med 2006, 19(1):8-20.